StockWatch
·
Specialty Chemicals
Quarterly ResultAug 6, 2026, 07:08 AM

Kenvue Merger with Kimberly-Clark Progresses; Q2 Net Sales $3.96B

AI Summary

Kenvue reported Q2 2026 net sales of $3.96 billion, up from $3.84 billion in Q2 2025, with diluted EPS increasing to $0.24 from $0.22. Year-to-date net income rose to $930 million from $742 million. The company also provided an update on its pending merger with Kimberly-Clark, confirming shareholder approval from both companies and the expiration of the HSR waiting period, with the transaction still awaiting foreign regulatory approvals.

Key Highlights

  • Merger with Kimberly-Clark approved by Kenvue and K-C shareholders.
  • Kenvue shareholders to receive 0.14625 K-C shares + $3.50 cash per share.
  • Q2 2026 Net Sales increased 3.0% to $3.96 billion.
  • Q2 2026 Diluted EPS rose 9.1% to $0.24.
  • YTD 2026 Net Income reached $930 million, up 25.3%.
  • YTD 2026 Operating cash flow was $1.18 billion, up 12.2%.
  • Total debt stood at $8.48 billion as of June 28, 2026.
  • Goodwill impairment assessment for Skin Health and Beauty showed no impairment.